Recognition of MHC class I-related chain (MIC) molecules on the surface of target cells by the activating receptor NKG2D leads to their lysis by immune effector cells. Up-regulation of NKG2D ligands is broadly related to stress, although the detailed molecular mechanisms that control the presence of these molecules at the plasma membrane are unclear. To investigate the posttranslational mechanisms that control surface expression of the human NKG2D ligand MICB, we studied the subcellular localization and trafficking of this molecule. We found that in several cellular systems, the expression of MICB molecules on the cell surface is accompanied by an intracellular accumulation of the molecule in the trans-Golgi network and late endosome-related compartments. Surprisingly, MICB has a much shorter half-life at the plasma membrane than MHC molecules and this depends on both recycling to internal compartments and shedding to the extracellular medium. Internalization of MICB depends partially on clathrin, but importantly, the lipid environment of the membrane also plays a crucial role in this process. We suggest that the brief residence of MICB at the plasma membrane modulates, at least in part, the function of this molecule in the immune system. The Journal of Immunology, 2009, 182: 4800 -4808.
M
ajor histocompatibility complex class I-related chain (MIC) 4 A and B are two MHC-like molecules encoded within the human MHC, but distinct from classical HLA class I proteins in that they bind neither ␤ 2 -microglobulin nor antigenic peptides (1) (2) (3) (4) . MIC proteins bind the activating receptor NKG2D that is constitutively expressed on all NK cells and CD8 ϩ T cell subpopulations and is upregulated after activation on CD4 ϩ T cells (5) . Engagement of NKG2D by its ligands leads to the activation of lysis and cytokine secretion by NK cells and T cells either directly or as a costimulatory factor (for review, see Ref. 6) . Thus, the presence of MIC at the surface of putative target cells must be tightly regulated so that the immune response is not triggered or hidden inappropriately (which would lead to autoimmunity in the first instance and immune evasion in the latter). In fact, with the exception of gastrointestinal epithelium, the vast majority of normal cells do not express MIC molecules at the cell surface; instead, the expression of these proteins is up-regulated in a number of pathological situations, mainly cancer and autoimmunity (for review, see Refs. 7 and 8). For example, MIC expression has been found in tumors of various origins and the presence of pathogens like Mycobacterium tuberculosis has been shown to up-regulate its expression (9) . Recently, a number of external stimuli such as DNA-damaging agents and proteasome inhibitors have been shown to induce expression of NKG2D ligands (10, 11) . Thus, although the precise mechanisms that regulate MIC expression are still unknown, the presence of MIC at the plasma membrane can be related broadly with stress and this coincides with the presence of heat shock elements in the MIC promoters (3) . The fact that MIC was detected by Western blot in a number of nontransformed cell types, including keratinocytes, endothelial cells, and monocytes, although they were not found at the cell surface of all of them (2, (12) (13) (14) , suggests the existence of posttranscriptional and posttranslational mechanisms regulating MIC expression, in addition to transcriptional regulation. That NKG2D ligands can also be shed from the cells as soluble molecules represents an additional level of complexity in this system (15) (16) (17) .
MICB is a target for several proteins expressed by pathogens that are involved in immune evasion. Interestingly, many of them are selective toward MICB and they do not affect the related protein MICA (18) . There are still many questions about the large number of NKG2D ligands and whether this diversity reflects somehow a difference in function (for review, see Ref. 19) .
With the goal of investigating the mechanisms that control surface expression of MICB molecules at a posttranslational level, we studied the subcellular localization and trafficking of MICB. In the present study, we show, in several cell lines, that the expression of MICB molecules on the cell surface is accompanied by an intracellular accumulation of the molecule in the trans-Golgi network (TGN) and late endosome-related compartments. We further show that MICB has a short half-life at the plasma membrane and that this depends on shedding and clathrin-dependent endocytosis, although the integrity of cholesterol in the plasma membrane also influences the internalization of MICB protein.
Materials and Methods

Cells, reagents, and Abs
HeLa, U373, and CV1 cells were maintained in DMEM supplemented with 10% FCS and antibiotics (DMEM/10% FCS). 721.221 and HCT116 were cultured in RPMI 1640 medium with 10% FCS and antibiotics.
721.221, U373, and CV1 transfected with MICB were previously described (20, 21) . Anti-MICA/B monoclonal and polyclonal Abs were purchased from R&D Systems, anti-MICA (AMO1) and anti-MICB (BMO2) were from Immatics, anti-MICA/B 6D4 was from Santa Cruz Biotechnology, and isotype control mouse mAbs were purchased from Sigma-Aldrich. For microscopy, sheep Ab directed against human TGN46 was from Serotec, mouse mAb specific for GM130 and early endosome A1 (EEA1) were from BD Biosciences, mouse anti-human CD107a (lysosome-activated membrane (LAMP-1)) was from Southern Biotechnology Associates; mouse KDEL mAb was from Bioquote; rabbit anti-mouse tetramethyl rhodamine isothiocyanate from DakoCytomation; Alexa Fluor 564 donkey anti-sheep, Alexa Fluor 488 donkey anti-sheep, Alexa Fluor 488 goat anti-mouse, and Alexa Fluor 488 and 564 goat anti-rabbit Abs were from Molecular Probes; and anti-CI-M6PR polyclonal rabbit Ab was a gift from P. Luzio (Cambridge Institute for Medical Research, Cambridge, U.K.). Anti-caveolin Ab was from BD Transduction Laboratories. Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich.
Flow cytometry
For flow cytometry, 10 5 cells were incubated with mouse mAbs and bound Ab was visualized using either PE-or FITC-labeled F(abЈ) 2 of goat antimouse Ig (DakoCytomation). Samples were analyzed using a FACScan II flow cytometer (BD Biosciences).
Confocal microscopy
Cells were fixed with 4% p-formaldehyde at room temperature for 10 min, permeabilized by incubation with 0.1% saponin at room temperature for 10 min, stained with commercial anti-MICB Abs (R&D Systems) or costained with markers for intracellular compartments, and analyzed by confocal microscopy as previously described (22) .
All fluorescence images were obtained using a confocal microscope (either a Leica DM IRE2 or IRBE confocal laser-scanning microscope). Excitation wavelengths and filter sets were as supplied by the manufacturer (lines at 488 and 568 nm for Alexa Fluor 488 and Alexa Fluor 568, respectively). To reduce Förster resonance energy transfer, the emission spectrum for the first fluorochrome was made distinct from the excitation spectrum of the second, i.e., the setting of the spectra was narrowed down to 500 -560 and 580 -660 nm for Alexa Fluor 488 and Alexa Fluor 568, respectively. Images of fixed cells were taken using a 63 ϫ 1.32 aperture objective with the confocal pinhole set to 1Airy unit. Image acquisition. Images were obtained by scanning either a single focal plane or a series of them across the cell using Leica TCS software. For colocalization experiments, acquisition of images was conducted by successive scanning of the 488 (green) and the 568 (red) channel, exciting one fluorochrome at a time by successive scanning of the green and the red channels independently. To explore the whole intracellular area, series of sections (total interval z ϭ 2-4 m) were acquired. Image acquisition of the subsequent sections was conducted near the resolution limit of the optical system used, i.e., the optimal for a good analysis of colocalization: 1024 ϫ 1024 pixels at z intervals of 0.1221 m with a magnification of 3-4 times. Colors and overlays shown in the figures were as collected by the microscope software and no further threshold adjustments were made. Adobe Photoshop software was used for composition of the figures. Image analysis and quantitation. For visualization of colocalization, images of composed overlays are presented in the manuscript; however, to analyze the degree of colocalization taking in account the three-dimensional nature of the sample, imaging processing was performed (data are included in Table I ). Huygens Deconvolution Software (Scientific Volume Imaging) was used for deconvolution and analysis.
ELISA
Detection of soluble MICB was performed using a sandwich ELISA procedure. The anti-MICB mAb from R&D Systems was used at 5 g/ml.
After blocking for 1 h with PBS containing 2% BSA, tissue culture supernatant was incubated for 1 h at 37°C. The assay was developed using biotinylated goat anti-MICB (0.1 g/ml) followed by incubation with streptavidin-HRP (1/2000; Amersham Biosciences) and a peroxidase substrate system (2,2Ј-azino-di-[3-ethylbenzthiazoline sulfonate] and H 2 O 2 in a glycine/citric acid buffer; Roche). The absorbance was measured at 410 nm with a reference wavelength of 490. Samples were analyzed in duplicates.
Internalization experiments
Ab uptake. Ab uptake experiments were performed as previously described (23) . Cells were incubated with Ab for 10 min at 4°C and then transferred to 37°C for different lengths of time. To detect internalized protein, cells were fixed, permeabilized, stained with secondary Ab, and analyzed by confocal microscopy. Cleavable biotinylation. For cleavable biotinylation experiments, the cells were washed three times with ice-cold PBS. Then incubated 30 min with 0.25 mg/ml sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate (EZ-Link Sulfo-NHS-SS-Biotin; Pierce) in ice-cold PBS containing 1 mM MgCl 2 and 0.1 mM CaCl 2 (PBSϩ). The reaction was quenched by washing the cells three times with ice-cold serum-free medium containing 0.1% BSA and then once with ice-cold PBSϩ. Prewarmed (to 37°C) serum-free medium was added for the desired time period(s) to allow internalization of the biotinylated surface components, after which they were returned to 4°C. After one rinse with PBSϩ, biotin was stripped by three 20-min incubations with ice-cold 100 mM sodium 2-mercaptoethane sulfonic acid (MESNA) in 50 mM Tris-HCl (pH 8.6), 100 mM NaCl, 1 mM EDTA, and 0.2% BSA. The cells were rinsed quickly twice again with PBSϩ, and residual MESNA was quenched by a 10-min incubation with ice-cold 120 mM iodoacetamide in PBSϩ. After two additional rinses with ice-cold PBS, the cells were lysed and MICB was immunoprecipitated. The proteins were resolved in SDS-PAGE and biotinylated proteins detected by Western blot with either streptavidin-HRP or MICB-specific Ab. Estimation of MICB internalization by flow cytometry. Internalization of MICB molecules was quantitated using a variant of a previously described flow cytometric assay for estimating receptor internalization (24) . Briefly, cells stably transfected with MICB were transiently transfected with plasmids encoding the AP180 C terminus, epsin1 R63L ϩH73L, and epsinR (gift from Dr. H McMahon, LMB, Cambridge, U.K.) and EH29 using JETPEI (PolyPlus Transfection SA). Twenty-four hours later, the cells were detached by incubation in PBS/0.2% BSA/10 mM EDTA, washed twice (PBS/BSA), and resuspended in binding buffer (Ham's F12 medium with 0.2% BSA, 10 M GM6001, and 1 mM HEPES). Transfected cells were divided into two aliquots and while one was held at 37 o C, the other was cooled to 4 o C. MICA/B-specific mAb (2.5 g/ml) was then added to each aliquot and the cells were incubated either at 37 o C or on ice for 30 min. After this time, the cells were washed into PBS/0.2% BSA/0.1% sodium azide and placed on ice followed by staining with PE-conjugated secondary goat anti-mouse Ig. Cells overexpressing the various constructs were gated on GFP fluorescence and the amount of MICB molecules remaining in the plasma membrane after the surface labeling with specific mAb was determined for each condition. Duplicate samples (5 ϫ 10 4 cells/ sample) were analyzed in each experiment. The reduction in surface receptor fluorescence after incubation at 37 o C compared with 4 o C represents internalization of receptors.
Pulse-chase experiments
Cells were washed and resuspended in either methionine-cysteine-free medium alone or with 100 M chloroquine or control. After a 30-min incubation at 37°C, cells were spun and resuspended at 10 7 cells/ml with PRO-MIX L-[
35 S] In Vitro Cell Labeling Mix (Amersham Biosciences) at 0.3 mCi/ml. Cells were incubated at 37°C for 15 min and then chased using complete medium with 10% FCS for the indicated times. Each time point sample was washed in cold PBS and resuspended in lysis buffer (50 mM Tris (pH 7.6), 150 mM NaCl, 5 mM EDTA, 1% (v/v) Nonidet P-40, 1 g/ml leupeptin, 1 g/ml pepstatin, and 5 mM iodoacetamide). After a 30-min incubation on ice, samples were precleared by incubation, first with Pansorbin (Calbiochem), followed by protein A-Sepharose beads (Pharmacia). MICB was immunoprecipitated by incubation on ice with the appropriate Ab and recovered using protein A beads. Samples were washed three times and resuspended in SDS-PAGE-loading buffer. Proteins were resolved in SDS-PAGE. Gels were stained and exposed on Biomax MR film (Kodak).
Immunoprecipitation
Cells were lysed in 50 mM Tris (pH 7.6), 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 1 g/ml leupeptin, and 1 g/ml pepstatin. After a 30-min incubation on ice, samples were precleared by incubation with Pansorbin (Calbiochem). MICB was immunoprecipitated by incubation on ice with a mixture of the MICB-specific Abs BMO2 and 6D4 and recovered using protein G beads (Pharmacia). Samples were washed three times and SDS-PAGE-loading buffer was added. Proteins were resolved in SDS-PAGE.
Western and dot blots
Cell lysates were run on 12% SDS-PAGE gels and transferred to Immobilon-P (Millipore). The membrane was blocked using PBS containing 0.1% Tween 20 (PBS-T) and 5% nonfat dry milk. Detection of MICB was performed by incubating the membrane with biotinylated goat polyclonal anti-MICB Ab, followed by HRP-conjugated secondary reagent. Proteins were visualized using the ECL system (Amersham Pharmacia). Detection of ganglioside GM1 was performed by immobilizing 5 l of the above fractions in nitrocellulose membrane, incubating with cholera toxin-HRP (Sigma-Aldrich), and detecting with ECL.
Detergent-resistant membrane (DRM) fractionation
Cells were lysed in TNE buffer (20 mM Tris (pH 7.5), 150 mM NaCl, and 5 mM EDTA) containing 1% Brij-58 and protease inhibitors and homogenized using a Dounce homogenizer. Samples were diluted with an equal volume of 85% sucrose in TNE and then placed at the bottom of a step sucrose gradient and fractionated by centrifugation for 18 -20 h at 200,000 ϫ g (25) . One-milliliter fractions were collected from top to bottom and made to a final concentration of 0.2% deoxycholate. Proteins were separated on SDS-PAGE. Western blot was performed as described above using Abs against MICA/B and caveolin-1. Efficiency of fractionation was assessed by detection of ganglioside GM1 using cholera toxin-HRP.
Results
MIC expression on the cell surface is accompanied by an intracellular accumulation of the molecule in late endosome/TGN-related compartments
In experiments exploring the mechanism of immune evasion used by human CMV (HCMV), we previously showed that HCMVinfected cells lost surface expression of MICB and accumulated MIC intracellularly. Interestingly, however, we observed that uninfected cells also expressed a large amount of intracellular protein (23) . To study this observation further, we analyzed the distribution of these molecules in a number of cell lines: HeLa and the colon carcinoma HCT116 naturally express MICA and MICB; the glioma cell line U373 and the monkey cell line CV1 were stably transfected with MIC molecules (U373/CV1-MICA and -MICB). The surface expression of MICA and MICB was studied by flow cytometry (Fig. 1A) . In general, MICB expression at the plasma membrane was lower than that of MICA, but MICB was found inside HCT116 cells in a larger proportion than MICA ( Fig. 1B ; whole intracellular area supplemental Fig. 1 5 ). Examination of both U373 and CV1 transfectants by confocal microscopy also showed quite a large proportion of MICB intracellularly (Fig. 1C) . Since the tumor cell lines HCT116 and HeLa express both MICA and MICB, it is difficult to confidently discriminate between these molecules, particularly since the Abs raised against either MICA or MICB could have different cross-reactivity depending on the alleles present in each cell line. For these reasons, we decided to focus on the study of transfectants in the following experiments.
To study the intracellular distribution of MICB molecules, cells were costained with markers for intracellular compartments and analyzed in confocal microscopy. Visualization of colocalization is presented as an overlay of the channels corresponding to MICB and the markers for different compartments (Fig. 2) . The perinuclear area where more MICB staining is found was magnified for intracellular analysis and is also included in Fig. 2 . To explore the whole intracellular area, series of sections were acquired through the cell (supplemental Fig. 2 ) and qualitative evaluation and quantification of data for colocalization purposes were performed (see Materials and Methods). The colocalization coefficients with the different markers are shown in Table I. MICB colocalized partially with the TGN markers TGN46 (data not shown) and cation-independent mannose-6-phosphate receptor (CI-M6PR), as well as partially with the endoplasmic reticulum 5 The online version of this article contains supplemental material. (ER) marker, KDEL, early endosomes (EEA1), and the late endosome marker CD63. Little colocalization was found with the other markers used: ER (PDI, ERp72; data not shown), medial Golgi (GM130), and LAMP-1. The CI-M6PR is involved in the sorting and transport of newly synthesized lysosomal hydrolases that contain mannose-6-phosphate moieties on their N-glycan chains, which serve as sorting signals for TGN-to-endosome transport and in steady state can be used as a marker for TGN (26) . LAMPs are lysosomal integral membrane glycoproteins and LAMP-1 is often used as a lysosomal marker, whereas CD63 (LIMP-I, LAMP-3) is a member of the tetraspanin superfamily enriched in intraluminal vesicles in late endosomes/lysosomes that can travel from the TGN to lysosomes (27) . It has been shown recently that LAMP-1 and LAMP-2 are present in separate TGN-derived vesicles from those containing mannose phosphate receptor and the adaptor protein AP-1 (28).
To confirm the TGN localization of MICB, cellular subfractionation was performed and the fractions were analyzed for the presence of MICB and organelle markers (supplemental Fig. 3) . MICB was detected in fractions enriched for markers of TGN, as well as in the fractions in which ER and early endosomes markers were found. The confocal microscopy and cellular subfractionation data would be consistent with MICB traveling between the TGN and the late endosomal system.
MICB has a short half-life at the plasma membrane
The presence of MICB molecules in late endosome/TGN-type organelles suggests that the molecule might be traveling within various compartments of the endocytic pathway and that some of the observed intracellular molecules could be the result of down-modulation from the plasma membrane. To follow the fate of the protein after it reaches the plasma membrane, Ab uptake experiments were performed and analyzed by confocal microscopy. After a 30-min incubation with Ab, a large proportion of MICB previously present at the plasma membrane was found intracellularly. The internalized MICB was then costained with markers for intracellular compartments (supplemental Fig. 4, A and B) . At short incubation times, MICB was observed in vesicles that did not colocalize with CI-M6PR, although after longer incubation times, some colocalization between MICB and CI-M6PR was noted.
The kinetics of MICB endocytosis was also studied in flow cytometry experiments. 721.221 cells transfected with MICB were stained with PE-labeled MICB-specific Ab and incubated for different periods of time to allow internalization. After the indicated times, Ab bound at the plasma membrane was removed by acid wash (29) and the Ab that remained in the internal compartments was detected by flow cytometry. Surface-bound Ab was efficiently removed by acid wash without affecting viability of the cells (at time 0 min, 94% of cells lost all of the staining after the acid wash and were still viable), and after incubation to allow internalization, endocytosed MICB staining was still observed (supplemental Fig. 4c ).
To rule out that the observed internalization of the protein was due to cross-linking with Ab, the phenomenon was studied in a biochemical assay independent of Ab. Cells were surface labeled with cleavable biotin and, after incubation at 37°C to allow internalization of the protein, the cells were treated with MESNA (a cell-impermeant reducing agent) to remove the biotin moiety from the labeled proteins that remain at the plasma membrane, after which only intracellular labeled proteins are detected. As a control for the proper elimination of surfacelabeled proteins, cells were incubated at 4°C and treated with MESNA. No biotinylated protein was detected, indicating that no MIC protein had been internalized (Fig. 3A, lane 2) . As a positive control, cells incubated at 4°C but not treated with MESNA showed the total amount of cell surface biotinylated MIC (Fig. 3A, lane 1) . This experiment shows a band corresponding to internalized protein in cells treated with MESNA after incubation at 37°C. This result confirms the ability of MICB to internalize. The various size bands of MICB observed in these experiments probably represent posttranslational modifications such as glycosylation. However it is also clear from this experiment that a significant amount of MIC protein is lost during this incubation at 37 o C. This could include both degradation and shedding to the extracellular medium.
Given that MIC proteins are known to be shed from the cell surface (15, 16), we next studied the dynamics of MIC expression and shedding in this system. To assess the stability of MICB molecules at the cell surface, flow cytometry experiments were performed using cycloheximide (CHX, to block protein synthesis), brefeldin A (BFA, inhibitor of vesicular trafficking), and a combination of both (Fig. 3B) . Interestingly, treatment with BFA and CHX led to a significant loss of MICB after 4 h, as did treatment with CHX alone (data not shown). A significant component of surface MICB must be involved in vesicular trafficking since the inclusion of BFA alone in the experiment also provoked a marked decrease in surface staining. Similar data were obtained in experiments with 721.221 cells transfected with MICB (data not shown). These data show that MICB is different than class I MHC proteins, which remain stably at the plasma membrane for 18 -24 h (30). An inhibitor of protein degradation, such as the weak base chloroquine (CHL), that raises the pH of late endosomes and lysosomes, impairing their function, was also included in the experiments. The stability of MICB at the cell surface was not affected by the presence of this compound. The shedding of MICB to the tissue culture medium was analyzed by ELISA (Fig. 3C) . Significant shedding of MICB was observed after 1 h of incubation and this soluble MIC accumulated over time (Fig. 3, inset) . Treatment with BFA, CHX, or CHL did not inhibit shedding. The fact that MICB is present in lysosome-related organelles, but that the levels of surface and soluble protein do not change when CHL is added suggest that the protein must be trafficking through these compartments rather than merely being degraded in lysosomes. This was confirmed by the inability of CHL treatment to alter the loss of MICB observed in pulse-chase experiments (Fig. 3D) . The marked loss of MICB seen by 3 h of chase confirmed biochemically the short half-life of MICB molecules suggested by the FACS experiments.
All together, these data suggest that, at steady state, MICB remains only for a short time at the plasma membrane and that the amount of MICB at the cell surface is most probably regulated by a combination of endocytosis and protein loss (by degradation and shedding).
MICB endocytosis and clathrin-dependent pathways
The mechanism of MICB endocytosis was next investigated. It is generally accepted that there are two main endocytic pathways based on the dependence or independence of clathrin (for review, see Refs. [31] [32] [33] [34] [35] . Both processes can be explored by the use of mutants or drugs that interfere with specific components necessary for the correct function of the pathway (reviewed in Ref. 36) .
Because the cytoplasmic tail of MICA/B molecules contain a dileucine motif that could bind AP2, we first studied clathrindependent endocytosis, a process that requires a variety of adaptor proteins and the generation of coated pits that bud into vesicles.
Eps15 is an adaptor protein found in clathrin-coated pits required for the early steps of clathrin-dependent endocytosis. The EH29 dominant-negative mutant of Eps15 affects the assembly of clathrin-coated pits and strongly inhibits transferrin receptor internalization (37, 38) . The effect of this construct on MICB endocytosis was studied in Ab uptake experiments, in which an inactive variant of Eps15 (DIII⌬2) was used as a control. To identify transfected cells, these variants of Eps15 are tagged with GFP (Fig. 4A) . After 20 min of Ab uptake, we could observe an accumulation of MICB in mock-transfected cells and cells expressing the inactive mutant, whereas in cells transfected with EH29 a considerable proportion of MICB was still at the plasma membrane. In supplemental Figs. 5 and 6, parallel experiments performing series of sections through the whole intracellular area are depicted. In these experiments, it is still possible to observe some intracellular MICB after inhibition of clathrin in the EH29 mutant, although not as much as in the inactive mutant DIII⌬2. Since clathrin blockade did not completely abolish MIC endocytosis, these data suggest that another mechanism of internalization might be involved.
To estimate the amount of MICB that was internalized via clathrin, flow cytometry experiments were performed. U373-MICB cells were transiently transfected with plasmids encoding the AP180 C terminus (inhibits clathrin-dependent budding events), epsin1 R63L ϩ H73L (inhibits AP2 budding events), epsinR (inhibits AP1 budding events), and EH29 (Fig. 4B) . We observed a marked reduction in internalization of cell surface MICB in cells transfected with AP180, epsin1 R63L ϩ H73L, and EH29.
In parallel, experiments using other methods to interfere with clathrin-mediated endocytosis were also performed. Hypertonic medium promotes the disappearance of clathrin-coated vesicles and plasma membrane-coated pits by preventing the interaction of clathrin with adaptors required for endocytosis (39) . Clathrin-dependent endocytosis can also be inhibited by the use of chlorpromazine (40) . Thus, Ab uptake experiments were also performed in the presence of chlorpromazine (Fig. 4C ) and 0.32 M sucrose (supplemental Fig. 7A ). The presence of these drugs impaired the uptake of MICB, confirming the data obtained previously.
MICB endocytosis and clathrin-independent pathways
Clathrin-independent endocytosis includes a group of pathways still not well characterized, but often associated with plasma membrane domains known as lipid rafts/caveolae. These microdomains are enriched in cholesterol, sphingolipids, and caveolin (for a review, see Refs. 41 and 42). Endocytosis via lipid rafts/caveolae is frequently defined using agents that disrupt or deplete cholesterol at the plasma membrane.
To find out whether "caveolin-mediated" endocytosis is involved in MICB down-modulation, we studied the ability of the protein to recycle from the plasma membrane in the presence of methyl-␤-cyclodextrin (M␤CD). M␤CD binds to cholesterol and selectively extracts it from the outer leaflet of the plasma membrane. We observed that cells preincubated with M␤CD accumulated MICB at the plasma membrane (Fig. 5A) , suggesting a role for cholesterol in the trafficking of MICB. As controls, fluorescently labeled transferrin and cholera toxin were included in the experiment. As expected, when M␤CD is present, a large proportion of cholera toxin remains at the plasma membrane, indicating a lower efficiency in its uptake. However transferrin, a protein internalized through clathrincoated pits, did get internalized, although with lower efficiency than in control cells. It has been previously shown that acute depletion of cholesterol also reduces the rate of internalization of transferrin (43, 44) . In supplementary Fig. 7B , a parallel experiment performing series of sections through the whole intracellular area is depicted. Flow cytometry analysis confirmed that treatment with M␤CD reduced the uptake of mAb specific for MICA/B (Fig. 5B) .
These results suggest that MICB is internalized through a clathrin-mediated, cholesterol-dependent pathway. Such a mechanism has been previously described for the entry of viruses and bacterial toxins in the cell (45, 46) .
MICB associates with DRMs
The finding that the trafficking of MICB could be influenced by the lipid environment led us to investigate the association of this protein with DRM domains. DRMs are microdomains rich in cholesterol and sphingolipids, especially GM1 ganglioside (41, 42) . DRMs can be separated from other membrane components by ultracentrifugation in sucrose gradients after solubilizing using detergents such as Triton X-100 or Brij-58 (47) . Caveolin-1, a component of caveolae, is usually found in DRMs and can be used as a marker for the efficiency of fractionation. As shown in Fig. 6 , a proportion of MICB was found in detergent-insoluble fractions rich in GM1 sphingolipid and caveolin-1. This finding confirms the location of at least some MICB molecules in domains of the membrane rich in cholesterol. 
Discussion
Given that recognition of NKG2D-L at the cell surface by their receptor leads to killing of the target cell, a very tight regulation of the expression of these proteins must exist. There are examples in the literature of cells that express mRNA for one or more of the NKG2D-L but do not show any expression of protein at the plasma membrane (48) . A posttranslational mechanism that involves the degradation of NKG2D-L RNA has been suggested as a manner of regulating the amount of these proteins in the cell (14) . In this study, we propose that the amount of MICB present at the cell surface can also be modulated by the particular features of the trafficking of the protein. Indeed, the main finding of the study is the short time of residence of MICB at the cell surface, confirmed by its rapid loss from the plasma membrane upon incubation with inhibitors of protein synthesis. Several cellular processes seem to be involved in the loss of MICB from the cell surface, including internalization toward intracellular compartments and shedding to the extracellular medium.
We show that MICB is endocytosed and trafficks through TGN and the endosomal/lysosomal system but most probably recycles back to the plasma membrane, since inhibitors of vesicular trafficking affect the amount of MICB at the cell surface (Fig. 2B) . It is clear that MICB is not present in lysosomes (membrane-bound acidic organelles that contain mature acid-dependent hydrolases and LAMPs but lack mannose-6-phosphate receptors), since it colocalizes with CI-M6PR and the increase of lysosomal pH does not affect the expression and shedding of MICB. Thus, MICB could be present in specialized compartments that share features of late endosomes/lysosomes but are functionally and morphologically distinct, such as the MHC class II compartment or other secretory organelles (49, 50) . However, multiple routes converge in the TGN and it will be important to further characterize the pathway followed by these molecules.
The short half-life of MICB at the plasma membrane of putative target cells is likely to have a direct effect on their function in recognition by the immune system. Given that NKG2D-L are indicators of cellular stress, their brief permanence at the cell surface suggests that continued expression requires continued stress. This may be a mechanism to minimize immune elimination of cells during transient situations of cell damage. Moreover, a rapid loss of MICB protein might be of crucial importance for the recognition of pathogens that affect the cellular machinery of transcription/translation. For example, it has long been known that herpesviruses switch off the synthesis of cellular proteins (51) . In this context, the short half-life of MICB would mean a rapid loss of surface protein, even after induction of MIC transcription.
There are still outstanding questions about the large number of ligands recognized by NKG2D and the way that several pathogens have evolved to affect particular ligands (18, 19) . For example, although only one HCMV product has been found to down-modulate MICA (52), several mechanisms target MICB, including UL16 (21, 53) and recently discovered virally encoded microRNAs (54) . The features of MICB trafficking described here might favor encounter with the hijacker UL16 protein within the cytoplasmic compartments or, alternatively, the viral protein could simply enhance a process that already happens in the uninfected cell.
Another finding from this work is that the mechanism of MICB endocytosis is dependent on clathrin but also affected by cholesterol. The involvement of lipids in clathrin-mediated pathways has been previously reported, especially for the uptake of toxins and viruses toward the cytoplasm (45, 46) . Also, internalization of the apolipoprotein E receptor 2 internalizes through a clathrin-mediated pathway after association with caveolar and noncaveolar lipid rafts (55) . Therefore, recent data support the existence of "hybrid" endocytosis and trafficking pathways in the cell whose mechanisms and functional significance remain unclear. The possibility of association of MICA with membrane lipids has been suggested (56); however, the presence of MIC protein in DRMs was not demonstrated biochemically. In this study, we could observe a proportion of MICB in DRMs and future work will focus on exploring the extent and significance of this finding. Further studies are also needed to fully understand the mechanisms by which MICB associates with lipids and the implications for trafficking and organization in the plasma membrane.
